482 Deciphering the heterogeneity of B-cell checkpoint inhibitors within tertiary lymphoid structures: Implications for lung cancer immunotherapy
Main Authors: | Corinne Ramos, Adele Ponzoni, Amandine Gerstenberg, Victor Senechal, Melodie Boute |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Heterogeneity of tertiary lymphoid structures in cancer
by: Xin You, et al.
Published: (2023-12-01) -
Tertiary Lymphoid Structures as Mediators of Immunotherapy Response
by: Raj G. Vaghjiani, et al.
Published: (2022-08-01) -
The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit
by: Yue Hou, et al.
Published: (2023-01-01) -
Immune Checkpoints and Innate Lymphoid Cells—New Avenues for Cancer Immunotherapy
by: Nicolas Jacquelot, et al.
Published: (2021-11-01) -
Advances in the study of tertiary lymphoid structures in the immunotherapy of breast cancer
by: Xin Li, et al.
Published: (2024-04-01)